Hyperbaric oxygen preconditioning attenuates hemorrhagic transformation through increasing PPARγ in hyperglycemic MCAO rats

Experimental Neurology

Volumn 265, Issue , 2015, Pages 22-29

  Bian, Hetao ^a,b   Hu, Qin ^a   Liang, Xiping ^a   Chen, Di ^a   Li, Bo ^a   Tang, Jiping ^a   Zhang, John H ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Jining First People's Hospital   (China)

Author keywords

Hemorrhagic transformation; Hyperbaric oxygen preconditioning; MCAO; PPAR

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; GELATINASE B; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE 15; OCCLUDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TIGHT JUNCTION PROTEIN; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL CULTURE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTERNAL CAROTID ARTERY; HEMORRHAGIC TRANSFORMATION; HYPERBARIC OXYGEN; HYPERGLYCEMIA; INTERVENTION STUDY; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; ANIMAL; BIOSYNTHESIS; CEREBRAL ARTERY DISEASE; CEREBRAL HEMORRHAGE; METABOLISM; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; CEREBRAL HEMORRHAGE; HYPERBARIC OXYGENATION; HYPERGLYCEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; MALE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84925259234     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.12.016     Document Type: Article

References (34)

1. Blanco M., Moro M.A., Davalos A., Leira R., Castellanos M., Serena J., Vivancos J., Rodriguez-Yanez M., Lizasoain I., Castillo J. Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke 2005, 36:1189-1194.
2. Chang T.H., Szabo E. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Res. 2000, 60:1129-1138.
3. Cheng O., Ostrowski R.P., Wu B., Liu W., Chen C., Zhang J.H. Cyclooxygenase-2 mediates hyperbaric oxygen preconditioning in the rat model of transient global cerebral ischemia. Stroke 2011, 42:484-490.
4. Chiu C.D., Chen C.C., Shen C.C., Chin L.T., Ma H.I., Chuang H.Y., Cho D.Y., Chu C.H., Chang C. Hyperglycemia exacerbates intracerebral hemorrhage via the downregulation of aquaporin-4: temporal assessment with magnetic resonance imaging. Stroke 2013, 44:1682-1689.
5. Cipolla M.J., Godfrey J.A. Effect of hyperglycemia on brain penetrating arterioles and cerebral blood flow before and after ischemia/reperfusion. Transl. Stroke Res. 2010, 1:127-134.
6. Culman J., Zhao Y., Gohlke P., Herdegen T. PPAR-gamma: therapeutic target for ischemic stroke. Trends Pharmacol. Sci. 2007, 28:244-249.
7. Dezfulian C., Garrett M., Gonzalez N.R. Clinical application of preconditioning and postconditioning to achieve neuroprotection. Transl. Stroke Res. 2013, 4:19-24.
8. Donnan G.A., Davis S.M., Parsons M.W., Ma H., Dewey H.M., Howells D.W. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat. Rev. Neurol. 2011, 7:400-409.
9. Fabian R.H., Kent T.A. Hyperglycemia accentuates persistent "functional uncoupling" of cerebral microvascular nitric oxide and superoxide following focal ischemia/reperfusion in rats. Transl. Stroke Res. 2012, 3:482-490.
10. Fagan S.C., Lapchak P.A., Liebeskind D.S., Ishrat T., Ergul A. Recommendations for preclinical research in hemorrhagic transformation. Transl. Stroke Res. 2013, 4:322-327.
11. Garcia J.H., Wagner S., Liu K.F., Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995, 26:627-634. (discussion 635).
12. Gillespie W., Tyagi N., Tyagi S.C. Role of PPARgamma, a nuclear hormone receptor in neuroprotection. Indian J. Biochem. Biophys. 2011, 48:73-81.
13. Hafez S., Coucha M., Bruno A., Fagan S.C., Ergul A. Hyperglycemia, acute ischemic stroke, and thrombolytic therapy. Transl. Stroke Res. 2014, 5:442-453.
14. Hu Q., Ma Q., Zhan Y., He Z., Tang J., Zhou C., Zhang J. Isoflurane enhanced hemorrhagic transformation by impairing antioxidant enzymes in hyperglycemic rats with middle cerebral artery occlusion. Stroke 2011, 42:1750-1756.
15. Jadhav V., Ostrowski R.P., Tong W., Matus B., Jesunathadas R., Zhang J.H. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Stroke 2009, 40:3139-3142.
16. Koch S. Moving towards preconditioning for neurological disorders: are we ready for clinical trials?. Transl. Stroke Res. 2013, 4:15-18.
17. Lehrke M., Lazar M.A. The many faces of PPARgamma. Cell 2005, 123:993-999.
18. Lin T.N., Cheung W.M., Wu J.S., Chen J.J., Lin H., Chen J.J., Liou J.Y., Shyue S.K., Wu K.K. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 2006, 26:481-487.
19. Luo Y., Yin W., Signore A.P., Zhang F., Hong Z., Wang S., Graham S.H., Chen J. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. J. Neurochem. 2006, 97:435-448.
20. Min L.J., Mogi M., Shudou M., Jing F., Tsukuda K., Ohshima K., Iwanami J., Horiuchi M. Peroxisome proliferator-activated receptor-gamma activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension 2012, 59:1079-1088.
21. Nosjean O., Boutin J.A. Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?. Cell. Signal. 2002, 14:573-583.
22. Paciaroni M., Agnelli G., Caso V., Corea F., Ageno W., Alberti A., Lanari A., Micheli S., Bertolani L., Venti M., Palmerini F., Billeci A.M., Comi G., Previdi P., Silvestrelli G. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc. Dis. 2009, 28:119-123.
23. Pereira M.P., Hurtado O., Cardenas A., Alonso-Escolano D., Bosca L., Vivancos J., Nombela F., Leza J.C., Lorenzo P., Lizasoain I., Moro M.A. The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke. J. Neuropathol. Exp. Neurol. 2005, 64:797-805.
24. Shaul P.W., Campbell W.B., Farrar M.A., Magness R.R. Oxygen modulates prostacyclin synthesis in ovine fetal pulmonary arteries by an effect on cyclooxygenase. J. Clin. Invest. 1992, 90:2147-2155.
25. Shaul P.W., Farrar M.A., Magness R.R. Oxygen modulation of pulmonary arterial prostacyclin synthesis is developmentally regulated. Am. J. Physiol. 1993, 265:H621-H628.
26. Soejima Y., Ostrowski R.P., Manaenko A., Fujii M., Tang J., Zhang J.H. Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats. Med. Gas Res. 2012, 2:9.
27. Soejima Y., Hu Q., Krafft P.R., Fujii M., Tang J., Zhang J.H. Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats. Exp. Neurol. 2013, 247:737-743.
28. Sundararajan S., Gamboa J.L., Victor N.A., Wanderi E.W., Lust W.D., Landreth G.E. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 2005, 130:685-696.
29. 2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. Biochem. Pharmacol. 2011, 82:1335-1351.
30. Tibbles P.M., Edelsberg J.S. Hyperbaric-oxygen therapy. N. Engl. J. Med. 1996, 334:1642-1648.
31. Wu J.S., Cheung W.M., Tsai Y.S., Chen Y.T., Fong W.H., Tsai H.D., Chen Y.C., Liou J.Y., Shyue S.K., Chen J.J., Chen Y.E., Maeda N., Wu K.K., Lin T.N. Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 2009, 119:1124-1134.
32. Xing Y., Jiang X., Yang Y., Xi G. Hemorrhagic transformation induced by acute hyperglycemia in a rat model of transient focal ischemia. Acta Neurochir. Suppl. 2011, 111:49-54.
33. Zeng Y., Xie K., Dong H., Zhang H., Wang F., Li Y., Xiong L. Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma. Brain Res. 2012, 1452:140-150.
34. Zhao X., Zhang Y., Strong R., Grotta J.C., Aronowski J. 15d-prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J. Cereb. Blood Flow Metab. 2006, 26:811-820.